All insiders/Insider trade history
9 insider transactions across 1 company, 2026-04-09 → 2026-04-17.
Total disclosed
$765K
Buys
$144K
Sells
$621K
Win rate · live
67%
Holdings
Marked using
shares-after from the latest filing × live quoteCompany
Trades
Holding value
Last trade
Avg buy / sell
% since last
MLYS
Mineralys Therapeutics, Inc.
Chief Medical Officer
9
$2.15M
70.2K sh
BUY
2026-04-17
$13.92
$27.98
+98.1%
Insider trade history
9 disclosed transactions
| Date | Ticker | Code | Shares | Price | Value | Now | % since |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | MLYS | M↑ | 416 | $15.44 | $6K | $30.58 | +98.1% |
| 2026-04-17 | MLYS | S↓ | 416 | $31.33 | $13K | $30.58 | -2.4% |
| 2026-04-15 | MLYS | S↓ | 6.3K | $27.66 | $176K | $30.58 | +10.6% |
| 2026-04-13 | MLYS | S↓ | 14.1K | $26.54 | $373K | $30.58 | +15.2% |
| 2026-04-13 | MLYS | M↑ | 4.2K | $14.25 | $59K | $30.58 | +114.6% |
| 2026-04-13 | MLYS | M↑ | 6.3K | $1.08 | $7K | $30.58 | +2731.5% |
| 2026-04-13 | MLYS | M↑ | 3.5K | $10.20 | $36K | $30.58 | +199.8% |
| 2026-04-09 | MLYS | M↑ | 2.2K | $16.00 | $35K | $30.58 | +91.1% |
| 2026-04-09 | MLYS | S↓ | 2.2K | $27.38 | $59K | $30.58 | +11.7% |
Transaction codes: P open-market buy · S open-market sell · A grant/award · M option exercise · F tax withholding · G gift. % since is the move from the trade-day reported price to the live quote.
Explore related topics
- All insider tradingLive ticker of every Form 4 filed across the U.S. equity market.
- Browse all insidersFull ranked index of every officer, director, and 10%+ holder we track.
- Super investorsSee which hedge funds also hold the same companies.
- Congress stock tradesPTR disclosures from U.S. lawmakers under the STOCK Act.
- Smart-money signalsWhere insider buys, 13F flows, and Congress trades all line up.
- Daily market digestOne-page roll-up of the day's most important smart-money events.